NATCOPHARM NATCO PHARMA LTD.
Healthcare
LTP
805.05
CHG · %
-1.95 (-0.24%)
VOL · TODAY
1.30L
PREV CLOSE
807
Today's range800 · 821.7
805.05
52-week range773.6 · 1,214.65
805.05
Loading candles…
Natco Pharma Limited, incorporated in 1981 and headquartered in Hyderabad, India, is a vertically integrated pharmaceutical company focused on research and development. The company develops, manufactures, and markets complex pharmaceutical products primarily in niche therapeutic areas such as oncology, including branded targeted therapies. Natco operates across multiple business segments including finished dosage formulations, active pharmaceutical ingredients, contract manufacturing, and a Crop Health Sciences division that provides pest management solutions leveraging its expertise in organic chemistry. It serves markets in India, the United States, and over 50 countries globally. The company emphasizes pharmaceutical exports of limited-competition molecules targeting high-entry-barrier markets while also operating in the agrochemical sector through its Crop Health Sciences division.
This page is a live market overview for NATCO PHARMA LTD. (NATCOPHARM) on the NSE. As a listed security, NATCO PHARMA LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NATCOPHARM before placing trades on tick2trade.
As of the latest feed, NATCOPHARM last traded at ₹805.05 on NSE, down ₹1.95 (0.24%) from the previous close of ₹807. Today's session range is ₹800 – ₹821.7, against a 52-week band of ₹773.6 – ₹1,214.65. Traded volume today stands at 1.30L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for NATCOPHARM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NATCOPHARM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NATCO PHARMA LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NATCOPHARM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NATCOPHARM option chain page linked from this overview.
// similar in healthcare326 total